In both groups of these cancers, the CREB-family member is activated by being incorporated in the protein encoded by the fusion and by being placed under the control of the EWSR1 or FUS promoter, both of which are transcriptionally active in the cells of origin of these tumors. This evidence concerns the gene FUS and cancer.